MediWound Ltd.
MDWD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5 | $6 | $4 | $6 |
| % Growth | -4.9% | 44.3% | -32.3% | – |
| Cost of Goods Sold | $5 | $4 | $3 | $5 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 16.5% | 23.5% | 18.7% | 15.5% |
| R&D Expenses | $3 | $3 | $3 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $4 | $3 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $7 | $6 | $7 |
| Operating Income | -$7 | -$6 | -$5 | -$6 |
| % Margin | -120.2% | -100.1% | -132% | -104.2% |
| Other Income/Exp. Net | $4 | -$8 | $5 | $2 |
| Pre-Tax Income | -$3 | -$13 | -$1 | -$4 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$13 | -$1 | -$4 |
| % Margin | -48.8% | -233.3% | -18.4% | -66.9% |
| EPS | -0.24 | -1.23 | -0.07 | -0.36 |
| % Growth | 80.5% | -1,657.1% | 80.6% | – |
| EPS Diluted | -0.24 | -1.23 | -0.067 | -0.36 |
| Weighted Avg Shares Out | 11 | 11 | 10 | 11 |
| Weighted Avg Shares Out Dil | 11 | 11 | 11 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $0 | $5 | $2 |
| Interest Expense | $0 | $8 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$2 | -$5 | -$0 | -$3 |
| % Margin | -40.2% | -85.7% | -9.2% | -59.8% |